data_1h6q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h6q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.542 ' CG ' HD21 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.542 HD21 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.543 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.409 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' CD2' ' C ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.589 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.49 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.464 ' O ' HG21 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.536 HG22 ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.589 ' CB ' ' CG2' ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.11 165.98 12.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -101.1 134.79 43.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 64' ' ' THR . 1.4 m -131.65 149.07 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.26 125.25 41.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.78 160.76 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -93.8 98.19 10.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -104.89 137.54 42.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.375 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.76 43.4 1.71 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.96 154.7 8.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 43' ' ' VAL . 8.4 t70 -144.88 -53.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.17 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 42' ' ' ASP . 95.8 t 43.77 81.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.487 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.17 -172.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 2.5 mp -93.81 57.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.342 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 47' ' ' ALA . . . 121.52 118.81 2.58 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 46' ' ' GLY . . . 169.18 49.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.585 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -146.51 141.96 16.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 109.482 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.49 -89.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.628 2.219 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -134.17 141.53 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.97 178.01 8.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -121.78 -25.13 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.0 t0 63.87 37.36 9.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.487 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -109.8 -63.59 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 10.4 mm-40 64.63 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.598 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -123.57 172.91 8.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.706 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -113.81 18.07 17.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.33 17.19 7.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 179.56 123.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -72.52 -69.36 0.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 0.0 109.62 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.62 55.44 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.43 124.59 28.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.55 129.82 43.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 34' ' ' MET . 9.0 t -83.16 139.96 32.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.73 156.43 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -60.68 152.41 26.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 HD12 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' HB2' ' CG2' ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 92' ' ' MET . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.491 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.551 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 59.3 t30 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.445 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.432 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.47 ' CE2' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 124' ' ' ASN . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 123' ' ' ALA . 12.4 m-80 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 128' ' ' TYR . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.559 ' CE1' ' O ' ' A' ' 131' ' ' TYR . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.485 HG21 ' OG ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 137' ' ' ASP . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.447 ' HE2' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.449 HG11 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.577 HG23 ' CE2' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.568 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.536 ' CG2' HG22 ' A' ' 27' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.577 ' CE2' HG23 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.458 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' N ' ' HG3' ' A' ' 160' ' ' LYS . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 163' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.543 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' HD23 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.486 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.725 ' HA ' HD23 ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.068 HD11 HD12 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.718 HG21 ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.626 ' H ' HG22 ' A' ' 14' ' ' VAL . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.631 ' CD2' HD11 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.11 165.98 12.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -101.1 134.79 43.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 64' ' ' THR . 1.4 m -131.65 149.07 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.26 125.25 41.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.78 160.76 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -93.8 98.19 10.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -104.89 137.54 42.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.375 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.76 43.4 1.71 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.96 154.7 8.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 43' ' ' VAL . 8.4 t70 -144.88 -53.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.17 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 47' ' ' ALA . 95.8 t 43.77 81.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.487 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.17 -172.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' ILE . 2.5 mp -93.81 57.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.342 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . 121.52 118.81 2.58 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . 169.18 49.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.585 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -146.51 141.96 16.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 109.482 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.49 -89.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.628 2.219 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -134.17 141.53 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.97 178.01 8.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -121.78 -25.13 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.0 t0 63.87 37.36 9.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.487 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -109.8 -63.59 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 10.4 mm-40 64.63 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.598 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -123.57 172.91 8.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.706 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -113.81 18.07 17.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.33 17.19 7.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 179.56 123.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -72.52 -69.36 0.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 0.0 109.62 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.62 55.44 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.43 124.59 28.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.55 129.82 43.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 34' ' ' MET . 9.0 t -83.16 139.96 32.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.73 156.43 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -60.68 152.41 26.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.631 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.856 ' HB2' HG22 ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' HE3' ' A' ' 89' ' ' LYS . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.5 ' HE3' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 9.9 t-20 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.784 ' O ' HD12 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 114' ' ' ALA . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HD22 ' A' ' 144' ' ' LEU . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.804 ' CE1' HG13 ' A' ' 142' ' ' VAL . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' N ' HD11 ' A' ' 132' ' ' ILE . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.804 HG13 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.623 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 143' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.477 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.068 HD12 HD11 ' A' ' 13' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' HD23 ' A' ' 2' ' ' LEU . 4.6 ptp . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.287 0.565 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.486 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -67.09 147.16 53.5 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 2' ' ' LEU . 57.9 mt -118.41 126.65 52.53 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.383 -0.823 . . . . 0.0 109.429 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.552 ' CD1' ' HA ' ' A' ' 165' ' ' SER . 75.8 m-85 -114.15 121.58 44.22 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.461 -0.774 . . . . 0.0 109.984 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.725 ' HA ' HD23 ' A' ' 13' ' ' LEU . 10.0 ptmt -126.37 160.79 29.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.616 -0.678 . . . . 0.0 109.228 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 141' ' ' MET . 25.6 t0 -98.86 154.08 18.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.329 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -95.36 -17.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.0 mt -75.43 -44.65 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 164.56 43.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.24 -41.94 3.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 57.1 99.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -1.19 . . . . 0.0 109.478 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 44.73 81.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.415 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.068 HD11 HD12 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -86.15 -32.06 21.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 110.019 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.718 HG21 ' CB ' ' A' ' 30' ' ' ALA . 8.2 p -166.91 174.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.966 -1.083 . . . . 0.0 109.529 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.626 ' H ' HG22 ' A' ' 14' ' ' VAL . 28.2 t -146.17 168.34 21.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.127 -0.983 . . . . 0.0 109.987 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.51 ' HA ' ' HG ' ' A' ' 20' ' ' LEU . 20.4 t0 -93.11 -4.59 52.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.323 -0.86 . . . . 0.0 109.483 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.18 -20.71 4.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.151 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.631 ' CD2' HD11 ' A' ' 68' ' ' LEU . 13.5 m-85 -99.08 -55.67 2.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.401 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 18' ' ' TYR . 3.3 m-20 155.44 130.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 30' ' ' ALA . 76.7 mt -130.27 133.56 46.59 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 118.894 -1.122 . . . . 0.0 111.046 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 mttp -131.43 127.52 37.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.2 pt-20 -92.9 129.59 38.77 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.058 -1.026 . . . . 0.0 109.614 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' ASP . 4.1 t -78.32 152.72 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -43.79 -28.46 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.884 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.728 ' O ' HG23 ' A' ' 26' ' ' ILE . 3.0 m-20 -65.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.728 HG23 ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -162.98 49.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.987 -1.071 . . . . 0.0 109.203 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 157' ' ' ILE . 6.7 m -140.57 151.42 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.654 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -100.6 157.63 16.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.081 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 2.2 tt0 -128.61 116.87 20.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.105 . . . . 0.0 109.629 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -107.24 112.82 25.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.109 -0.995 . . . . 0.0 108.958 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -73.89 146.64 43.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.979 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 p -125.04 148.54 48.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.828 . . . . 0.0 109.072 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.11 165.98 12.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.494 ' CG ' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -101.1 134.79 43.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 64' ' ' THR . 1.4 m -131.65 149.07 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.444 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.26 125.25 41.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.78 160.76 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.875 . . . . 0.0 109.385 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -93.8 98.19 10.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -104.89 137.54 42.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.375 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.76 43.4 1.71 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.96 154.7 8.24 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 43' ' ' VAL . 8.4 t70 -144.88 -53.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -1.17 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG12 ' HB3' ' A' ' 47' ' ' ALA . 95.8 t 43.77 81.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.487 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.17 -172.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 45' ' ' ILE . 2.5 mp -93.81 57.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.342 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . 121.52 118.81 2.58 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 46' ' ' GLY . . . 169.18 49.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -1.112 . . . . 0.0 109.585 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -146.51 141.96 16.86 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 109.482 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.49 -89.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.628 2.219 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -134.17 141.53 47.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.97 178.01 8.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 109.386 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -121.78 -25.13 5.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 0.0 109.529 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 47.0 t0 63.87 37.36 9.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.197 -0.939 . . . . 0.0 109.487 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -109.8 -63.59 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.87 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 10.4 mm-40 64.63 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.598 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -123.57 172.91 8.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 0.0 109.706 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -113.81 18.07 17.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.33 17.19 7.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 109.475 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 179.56 123.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -72.52 -69.36 0.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.358 -0.839 . . . . 0.0 109.62 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.62 55.44 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.43 124.59 28.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.55 129.82 43.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.501 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' CG ' ' A' ' 34' ' ' MET . 9.0 t -83.16 139.96 32.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.424 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.73 156.43 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.292 -0.88 . . . . 0.0 109.48 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -60.68 152.41 26.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 71' ' ' SER . 19.7 p30 -85.45 -17.77 35.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.975 . . . . 0.0 109.57 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.631 HD11 ' CD2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.09 -41.75 16.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 108.716 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.856 HG22 ' HB2' ' A' ' 74' ' ' LEU . 45.2 t -72.35 -36.69 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.411 -0.805 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -69.61 -43.18 73.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.6 OUTLIER -74.22 -27.94 61.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.936 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' C ' ' CD ' ' A' ' 73' ' ' ARG . 26.3 m-85 -114.39 16.66 17.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.458 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER 37.84 44.06 0.55 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.596 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.856 ' HB2' HG22 ' A' ' 69' ' ' VAL . 6.6 mt -49.44 142.85 7.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.997 -1.065 . . . . 0.0 108.566 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 132' ' ' ILE . 3.4 p -128.96 107.7 18.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.992 -1.067 . . . . 0.0 109.463 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 131' ' ' TYR . 35.8 Cg_endo -78.21 134.04 12.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.454 2.103 . . . . 0.0 110.247 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 159.69 29.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.319 -0.863 . . . . 0.0 109.729 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.75 164.36 24.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.182 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -150.24 179.98 7.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.778 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.59 153.62 36.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.218 -0.926 . . . . 0.0 109.105 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.83 -51.55 67.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 109.703 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -72.66 -31.32 65.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 109.529 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.5 m -66.15 -29.96 70.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.374 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 10.3 t80 -65.75 -36.87 84.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.362 -0.836 . . . . 0.0 109.703 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 3.1 mtt -64.66 -38.03 89.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 110.011 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.6 m -71.11 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.918 . . . . 0.0 110.496 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -77.27 -38.98 49.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' HE3' ' A' ' 89' ' ' LYS . 6.7 tp -76.34 -26.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.843 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.5 ' HE3' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -76.77 -56.38 4.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.02 . . . . 0.0 109.673 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.18 -23.0 73.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 91' ' ' TYR . 30.1 t80 -81.34 -40.7 23.16 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.022 -1.281 . . . . 0.0 108.918 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -63.47 -40.54 97.39 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 89' ' ' LYS . 0.5 OUTLIER -65.24 -38.53 90.65 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.94 -46.59 78.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.025 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 29.2 mm -64.74 -40.39 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.218 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -51.61 -38.09 53.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.133 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.13 64.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 0.0 109.68 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -59.9 -32.11 70.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' N ' ' HG3' ' A' ' 98' ' ' ARG . 50.6 mt -73.08 -47.35 45.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.137 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -55.34 -36.89 66.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.791 . . . . 0.0 109.751 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.59 -31.5 41.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.757 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.2 t -105.08 -78.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.723 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 99' ' ' LEU . 59.3 t30 -119.83 107.94 39.59 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.529 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.26 -19.78 19.42 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.385 2.057 . . . . 0.0 110.381 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -74.14 -11.43 60.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.214 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.544 ' HB3' HD22 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -94.1 0.71 56.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.489 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 108' ' ' PRO . 53.6 t -71.95 -43.23 10.64 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.183 -0.948 . . . . 0.0 111.29 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 107' ' ' VAL . 33.5 Cg_endo -76.45 -52.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.877 1.718 . . . . 0.0 111.085 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 106' ' ' ARG . 2.3 m -59.72 -36.99 69.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.997 -1.064 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 44.9 t80 -69.67 -37.34 76.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.4 -0.812 . . . . 0.0 110.276 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.784 ' O ' HD12 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -68.53 -48.78 63.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.092 -1.005 . . . . 0.0 110.868 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -49.47 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.057 . . . . 0.0 110.807 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 109' ' ' VAL . 2.5 m120 -64.49 -48.91 73.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.97 -1.081 . . . . 0.0 110.439 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.72 -32.09 73.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.169 -0.957 . . . . 0.0 110.255 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -68.27 -39.63 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.402 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.59 -47.82 73.77 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -42.09 97.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.988 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 114' ' ' ALA . 71.8 t -60.13 -35.53 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 0.0 109.847 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -68.18 -38.13 81.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.933 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -78.83 -17.56 55.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.94 . . . . 0.0 109.897 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.44 -37.87 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.166 -0.959 . . . . 0.0 109.678 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 15.7 mt -62.34 -31.63 72.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.659 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 124' ' ' ASN . . . -54.1 -26.29 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.636 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 123' ' ' ALA . 12.4 m-80 -154.76 54.53 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.349 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 126' ' ' LYS . 2.2 p90 -59.8 -22.13 61.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.639 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.444 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -76.58 -43.42 38.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.283 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -65.11 -26.39 68.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.853 . . . . 0.0 109.343 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 146' ' ' ASN . 4.9 m-85 -85.11 -12.24 53.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.431 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HD22 ' A' ' 144' ' ' LEU . 4.1 m-20 50.88 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.667 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.804 ' CE1' HG13 ' A' ' 142' ' ' VAL . 2.7 t80 -139.07 121.23 15.79 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CE1' ' A' ' 130' ' ' PHE . 9.1 m-85 -103.36 170.69 7.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.056 -1.028 . . . . 0.0 110.669 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 75' ' ' SER . 2.0 tt -156.54 142.68 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.65 -178.94 51.87 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.421 ' OE1' ' HG2' ' A' ' 73' ' ' ARG . 3.6 mp0 -64.36 -19.45 65.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -1.095 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 136' ' ' MET . 82.6 p -56.01 -33.58 65.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.282 -0.886 . . . . 0.0 109.146 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.491 ' HB2' ' O ' ' A' ' 135' ' ' SER . 13.7 mmt 64.7 53.86 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.572 -0.705 . . . . 0.0 109.494 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' N ' HD11 ' A' ' 132' ' ' ILE . 6.4 t0 -128.96 120.12 20.2 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.323 -0.86 . . . . 0.0 109.176 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.98 2.67 6.37 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.286 1.99 . . . . 0.0 110.559 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.78 12.94 11.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.275 -0.891 . . . . 0.0 109.197 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.39 -156.87 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 159' ' ' PHE . 0.0 OUTLIER -64.5 121.53 14.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.804 HG13 ' CE1' ' A' ' 130' ' ' PHE . 94.4 t -106.35 120.27 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.549 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.623 HG11 ' CZ ' ' A' ' 158' ' ' PHE . 7.2 t -109.46 141.52 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.164 -0.96 . . . . 0.0 109.485 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 129' ' ' ASP . 53.1 mt -114.65 141.42 47.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 0.0 108.965 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.1 ttm -104.8 119.68 39.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.071 -1.018 . . . . 0.0 109.522 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.586 ' HB2' ' CD1' ' A' ' 128' ' ' TYR . 44.6 t30 -138.09 146.72 43.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 151' ' ' GLY . 0.9 OUTLIER -87.3 146.2 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.885 . . . . 0.0 109.541 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -58.75 -171.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.402 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.29 -17.46 64.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.248 -0.907 . . . . 0.0 109.481 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -53.49 4.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.296 -0.878 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.541 ' O ' ' CD1' ' A' ' 147' ' ' TYR . . . 114.89 -24.72 10.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 152' ' ' ILE . 1.3 tp -85.18 3.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.291 -1.123 . . . . 0.0 109.634 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 m -123.67 101.18 36.94 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.167 -0.958 . . . . 0.0 109.665 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.6 122.82 5.13 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.509 2.14 . . . . 0.0 109.924 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 5.9 p90 -141.03 148.66 40.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.28 158.6 26.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.436 -0.79 . . . . 0.0 109.022 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 143' ' ' VAL . 41.6 mt -116.64 141.93 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.235 -0.916 . . . . 0.0 110.02 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 4.5 m-85 -126.3 113.69 17.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.477 ' HB3' ' OD2' ' A' ' 161' ' ' ASP . 8.0 m-85 -42.93 119.31 1.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -68.06 -28.58 67.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.865 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 159' ' ' PHE . 3.3 p30 -57.63 -39.7 77.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -105.93 43.04 1.76 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.068 HD12 HD11 ' A' ' 13' ' ' LEU . 3.6 tt -142.47 125.76 16.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.44 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 0.2 OUTLIER -112.77 157.42 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.552 ' HA ' ' CD1' ' A' ' 4' ' ' TYR . 1.7 m -101.49 139.21 37.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -128.08 123.17 33.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -90.57 139.32 30.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 stop_ save_